Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
87,836,766
-
Share change
-
+2,028,857
-
Total reported value
-
$10,681,247,146
-
Put/Call ratio
-
85%
-
Price per share
-
$121.59
-
Number of holders
-
457
-
Value change
-
+$238,081,360
-
Number of buys
-
207
-
Number of sells
-
218
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q4 2024
As of 31 Dec 2024,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
457 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,836,766 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Capital International Investors, JANUS HENDERSON GROUP PLC, STATE STREET CORP, FARALLON CAPITAL MANAGEMENT LLC, Avoro Capital Advisors LLC, Bank of New York Mellon Corp, WELLINGTON MANAGEMENT GROUP LLP, and JPMORGAN CHASE & CO.
This page lists
460
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.